RAPID COMPETITIVE LANDSCAPE REPORTING
LIFE SCIENCES PROFESSIONAL SERVICES
Rapid Insight Reports can deliver
• The key insights to help you make informed
decisions faster
• Preclinical and clinical drug pipeline
intelligence
• Deals landscaping in diseases and by company
• Current standards of care and developing
treatments
• Comparisons of drug, medical device, and
treatment protocols
Who can benefit
•
•
•
•
•
•
•
•
Researchers
Disease Area Strategy Teams
Competitive Intelligence Professionals
Heads of Therapy Area
VPs R&D
VPs Clinical Development
Business Development Teams
Portfolio Managers
In today’s environment, developing comprehensive
competitive insights on a timeline that meets your
business requirements can stretch your in-house
resources. Rapid Insight Reports from Thomson
Reuters Professional Services provides you with
the information you need, when you need it.
Our expert consultants can quickly identify key
information from our industry leading databases,
public domain sources, and other commercial
sources to develop custom reports that offer
you penetrating, objective insights quickly. From
detailed information about targets of interest to a
complete overview of the clinical landscape, trust
Thomson Reuters to deliver.
CALL TO ACTION TO GO HERE.
find out more.
Visit go.thomsonreuters.com/
professional_services
Copyright © 2012 Thomson Reuters
Thomson Reuters can put a full data analysis in
your hands fast so you spend less time working with
data and more time making informed decisions.
Rapid Insight Reports can answer questions like:
• What are the current treatment options for a
therapy area or disease state?
• Which companies have launched or are
developing treatments?
• What is the IP position of competitive therapies?
• Which clinical or regulatory developments
could affect the competitive landscape?
ABOUT PROFESSIONAL SERVICES
Thomson Reuters works with you to provide new
disease understanding, therapeutic and business
insights, and better decision-support capabilities.
We combine expert analysts in use of our content
and technology assets, proprietary analytical
and visualization tools, and deep expertise in the
pharmaceutical and life sciences business so you
can benefit from tailored solutions that meet your
unique business needs for faster, more informed
decisions with higher confidence.